The objective of this program is to train pharmaceutical scientists to handle the development of products arising from biotechnology research (i.e., therapeutic drugs and vaccines). Due to the difficulty and complex nature of developing biotechnology-derived drugs, it is necessary to train a new "breed" of pharmaceutical scientists who can respond to the need for interdisciplinary approaches for the advancement of biological, chemical, and pharmaceutical sciences by integrating mathematics, physics, biology, molecular biology, and chemistry to solve difficult problems in designing therapeutic agents of the future. This new type of scientist could also be employed in academic institutions to expand the educational training of future pharmaceutical biotechnology scientists. This training program has been in existence for 26 years with 37 faculty mentors and eight students will be in the training program. There are three major areas of research in this training program: (1) the traditional "pharmaceutics" area that includes formation, analysis, and delivery, (2) the protein structure and bioinformatics area, and (3) the vaccine stabilization and formulation area. The 37 faculty mentors are from various departments (e.g., Chemistry, Medicinal Chemistry, Mechanical Engineering, Molecular Biosciences, and Pharmaceutical Chemistry, etc.) and Centers (Adams Institute for Bioanalytical Chemistry, Bioengineering and Bioinformatics Centers). The Steering Committee oversees all aspects of the Biotechnology Training Program;Drs. Siahaan and Volkin serve as the PI and Co-PI of the program, respectively. The students will be selected from a pool of applicants that are nominated by the faculty mentors from the participating departments. The Steering Committee will select the trainees from the nominated students each year. The trainees have to take required and elective courses for the training program including a course on responsible conduct in research. The students are also required to do 3-6 months industrial internship. The students'progress will be monitored in quarterly meetings and annual KU retreat. The trainees organize the Joint CU-KU Symposia, which is a joint symposium with the Biotechnology Training Program at the University of Colorado. The trainees will be supported by the training program for a maximum of two years. The alumni of this program who have been working for five years in industry and academia will be invited to present their research at the yearly KU retreat as well as to provide feedback on the training program.

Public Health Relevance

The mission of the training program is to produce future scientists that will work in the area of pharmaceutical biotechnology to support development of biotechnology products (i.e., therapeutic drugs and vaccines) for improving human health in US and globally.

Agency
National Institute of Health (NIH)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM008359-24A1
Application #
8742968
Study Section
(TWD)
Program Officer
Gerratana, Barbara
Project Start
Project End
Budget Start
Budget End
Support Year
24
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Kansas Lawrence
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
Lawrence
State
KS
Country
United States
Zip Code
66045
Mills, Brittney J; Laurence, Jennifer S (2015) Stability analysis of an inline peptide-based conjugate for metal delivery: nickel(II)-claMP Tag epidermal growth factor as a model system. J Pharm Sci 104:416-23
Telikepalli, Srivalli N; Kumru, Ozan S; Kalonia, Cavan et al. (2014) Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions. J Pharm Sci 103:796-809
Alsenaidy, Mohammad A; Okbazghi, Solomon Z; Kim, Jae Hyun et al. (2014) Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297. J Pharm Sci 103:1613-27
Dennis, S Connor; Detamore, Michael S; Kieweg, Sarah L et al. (2014) Mapping glycosaminoglycan-hydroxyapatite colloidal gels as potential tissue defect fillers. Langmuir 30:3528-37
Rathinavelan, Thenmalarchelvi; Lara-Tejero, Maria; Lefebre, Matthew et al. (2014) NMR model of PrgI-SipD interaction and its implications in the needle-tip assembly of the Salmonella type III secretion system. J Mol Biol 426:2958-69
Mills, Brittney J; Mu, Qingxin; Krause, Mary E et al. (2014) claMP Tag: a versatile inline metal-binding platform based on the metal abstraction peptide. Bioconjug Chem 25:1103-11
Creamer, Jessica S; Krauss, Shannon T; Lunte, Susan M (2014) Capillary electrophoresis separation of the desamino degradation products of oxytocin. Electrophoresis 35:563-9
Naik, Subhashchandra; Kumru, Ozan S; Cullom, Melissa et al. (2014) Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry. Protein Sci 23:1461-78
Logan, Randall; Kong, Alex C; Krise, Jeffrey P (2014) Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts. J Pharm Sci 103:3287-96
Dormer, Nathan H; Gupta, Vineet; Scurto, Aaron M et al. (2013) Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres. Mater Sci Eng C Mater Biol Appl 33:4343-51

Showing the most recent 10 out of 56 publications